Overview

The Beijing United Integrated Oncology Center (BJIOC) is a comprehensive international oncology center providing patient-centered, precision cancer care based on international standards. We deliver a full continuum of oncology services, from prevention and early screening to diagnosis, personalized treatment, rehabilitation, and long-term follow-up.

Unlike the traditional single-specialty approach, BJIOC adopts a multidisciplinary team (MDT) model supported by eight oncology subspecialty teams and five integrated care pathways. Our one-stop approach streamlines the patient journey—from early cancer screening and precision diagnosis to individualized treatment, rehabilitation, and survivorship care—providing efficient, private, and coordinated services for both domestic and international patients.

Key Advantages

• New cancer cases receive an MDT treatment plan within 72 hours.
• Domestic expert consultations are completed within 2 days.
• International multidisciplinary consultations are completed within 4 days.
• An efficient clinical pathway minimizes delays and accelerates diagnosis and treatment.

• Eight dedicated oncology subspecialty teams covering breast, thoracic, gastrointestinal, urologic, gynecologic, thyroid, bone and soft tissue cancers, as well as oncology rehabilitation.
• Every patient benefits from multidisciplinary evaluation and an individualized treatment plan.
• A dedicated oncology center at the Dongcheng Campus provides integrated services from screening and surgery to chemotherapy, radiotherapy, and rehabilitation.

• Five integrated care pathways covering cancer prevention, AI-assisted early screening, international-standard treatment, physical and psychological rehabilitation, and dedicated case management.
• Continuous support from risk assessment and early intervention through treatment, recovery, and long-term follow-up.
• Dedicated case managers coordinate care throughout the patient journey.

• AI-assisted imaging analysis for early lesion detection.
• Precision diagnostics supported by tumor marker assessment, genetic testing, and methylation testing.
• Intelligent follow-up systems supporting personalized long-term recovery and survivorship care.

• Led by Professor Zhu Gang and supported by experienced specialists in oncology, surgery, medical oncology, radiology, pathology, rehabilitation, and psycho-oncology.
• Clinical practice follows internationally recognized AJCC TNM staging and treatment guidelines.
• Individualized treatment strategies for both common and complex cancer cases.

Technology & Facilities

BJIOC is equipped with advanced oncology technologies and AI-enabled clinical systems supporting precision screening, minimally invasive treatment, intelligent monitoring, and digital follow-up. Our capabilities include AI-assisted imaging, genetic testing, circulating tumor cell (CTC) testing, and methylation screening to improve early cancer detection.

All clinical services follow international medical standards with standardized, traceable care pathways. Through remote monitoring and cross-border consultation services, patients can access expert oncology care and international specialist resources with greater convenience.